A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort.

PLoS One · 2023 · PMC9844906 · PMID 36649371

Europe PMC DOI

hedged sentence

0.4600

closest p · 9.2× alpha

0.4600

boldest claim

The sentences

showed a trendp = 0.46not close (p > 0.1)

The intermediate risk group showed a trend to reduction in mortality (17.8% to 10.3%, aHR 0.82, p = 0.46) which was not observed in the low risk group (7.8% to 9.2%, aHR 1.4, p = 0.31).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.